Multi-Pathogen Vaccine

Product

Last mentioned: 2d ago

Timeline

Invalid Date
Phase I Trials

Anticipated start of first-in-human safety and dosage escalation studies.
Invalid Date
IND Filing

Target window for filing an Investigational New Drug application with the FDA.
Invalid Date
Pre-clinical Completion

Expected conclusion of animal model testing and toxicology reports.
Feb 20, 2026
Study Publication

Stanford University researchers publish findings on a multi-pathogen vaccine candidate.

Stories mentioning Multi-Pathogen Vaccine 1

Stanford Breakthrough: Universal Vaccine Strategy Targets Multiple Pathogens

Researchers at Stanford University have unveiled a novel vaccine candidate designed to provide broad-spectrum protection against a variety of viral infections. This multi-pathogen approach marks a significant shift from traditional strain-specific immunizations toward a more resilient public health defense.

2d ago 2 sources